CD69 and glioblastoma: In murine glioblastoma models undergoing immune checkpoint inhibitor therapy, [18F]AlF-NOTA-CD69 antibody selectively accumulated in tumors treated with immune checkpoint inhibitors, correlating strongly with increased CD69 expression on tumor-infiltrating lymphocytes.